Comment Resolutions: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 128: | Line 128: | ||
| [[Media:QIBA US SWS Comments 2023-02-20-v2.xlsx| Clinically Feasible Comment Resolutions 2023-02-20]] | | [[Media:QIBA US SWS Comments 2023-02-20-v2.xlsx| Clinically Feasible Comment Resolutions 2023-02-20]] | ||
|- | |- | ||
| [[Media:QIBA US SWS Profile 2023-02-07.pdf|US Shear Wave Speed for Liver Fibrosis 2023-02-07]] | | [[Media:QIBA US SWS Profile 2023-02-07.pdf|US Shear Wave Speed for Liver Fibrosis 2023-02-07, marked-up version]] | ||
| Clinically Feasible | |||
| 2023.12.13 | |||
| [[Media:2023_12_13_SWS BC QIBA Technical Confirmation Resolutions.xlsx | Clinically Feasible Comment Resolutions 2023-12-13]] | |||
|- | |||
| [[Media:SWS Profile Final Candidate_February_07_2023_CLEAN.pdf|US Shear Wave Speed for Liver Fibrosis 2023-02-07, clean version]] | |||
| Clinically Feasible | | Clinically Feasible | ||
| 2023.12.13 | | 2023.12.13 | ||
Revision as of 22:49, 14 December 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.